Panacea Index Logo

Command Palette

Search for a command to run...

Internet-delivered mindfulness-based cognitive therapy for anxiety and depression in cancer survivors: A randomized controlled trial.

Psycho-oncology
January 1, 2020
Eva Rames Nissen et al. (7 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to test the efficacy of therapist-assisted internet-delivered mindfulness-based cognitive therapy (iMBCT) for reducing anxiety and depression in cancer survivors.

Results Summary

iMBCT showed significant effects for reducing anxiety (Cohen's d = 0.45) and depressive symptoms (d = 0.42) post-intervention, with anxiety benefits maintained at 6-month follow-up, but not depressive symptoms.

Population

Breast (n = 137) and prostate cancer (n = 13) survivors with anxiety and depression.

Effective Dosage

Not specified

Duration

10 weeks

Interactions

None mentioned

Extracted Claims (4)
InterventionDirectionEndpointPopulationDosageImpactClaim #
therapist-assisted internet-delivered mindfulness-based cognitive therapy (iMBCT)
decrease
anxiety
cancer survivors
Cohen's d = 0.45
Significant effects were found
#1
therapist-assisted internet-delivered mindfulness-based cognitive therapy (iMBCT)
decrease
depressive symptoms
cancer survivors
Cohen's d = 0.42
Significant effects were found
#2
therapist-assisted internet-delivered mindfulness-based cognitive therapy (iMBCT)
decrease
anxiety
cancer survivors
Cohen's d = 0.40
The effects were maintained at follow-up
#3
therapist-assisted internet-delivered mindfulness-based cognitive therapy (iMBCT)
no change
depressive symptoms
cancer survivors
Cohen's d = 0.28
not maintained at follow-up
#4
Abstract

OBJECTIVE: Internet-delivered interventions may alleviate distress in cancer survivors with limited access to psychological face-to-face treatment. In collaboration with a group of cancer survivors, we developed and tested the efficacy of a therapist-assisted internet-delivered mindfulness-based cognitive therapy (iMBCT) program for anxiety and depression in cancer survivors. METHODS: A total of 1282 cancer survivors were screened for anxiety and depression during their routine oncology follow-up; eligible breast (n = 137) and prostate cancer (n = 13) survivors were randomized to iMBCT or care-as-usual (CAU) wait-list. Primary outcomes of anxiety and depression were assessed at baseline, 5 weeks, 10 weeks (post intervention), and 6 months. RESULTS: Significant effects were found for both anxiety (Cohen's d = 0.45; P = .017) and depressive symptoms (d = 0.42; P = .024) post intervention. The effects were maintained at follow-up for anxiety (d = 0.40; P = .029), but not for depressive symptoms (d = 0.28; P = .131). CONCLUSIONS: Our preliminary findings suggest iMBCT to be a helpful intervention for cancer survivors suffering from symptoms of anxiety. Further studies on the efficacy for symptoms of depression are needed.

Medical Subject Headings (MeSH)
AdultAnxietyCancer SurvivorsCognitive Behavioral TherapyDepressionFemaleHumansInternet-Based InterventionMaleMiddle AgedMindfulness
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality85/10
Citation Metrics
Total Citations68
Citations/Year13.6
Relative Citation Ratio5.05
NIH Percentile93.2%
Research Impact Scores
APT Score0.95
Weight Score2.75
Normalized Score0.67
Related Supplements